Pick the best stocks and maximize your portfolio:
- Discover top-rated stocks from highly ranked analysts with Analyst Top Stocks!
- Easily identify outperforming stocks and invest smarter with Top Smart Score Stocks
Cambridge Cognition Holdings ( (GB:COG) ) has issued an update.
Cambridge Cognition Holdings announced that Non-Executive Director Stuart Gall has purchased 31,250 ordinary shares of the company at 32 pence per share, bringing his total to 68,750 shares. This transaction reflects insider confidence in the company’s future prospects and positions Cambridge Cognition more favorably in the digital health market by highlighting its leadership’s commitment to their innovative brain health solutions.
More about Cambridge Cognition Holdings
Cambridge Cognition is a leading technology company specializing in digital health products that focus on advancing brain health research and treatment. The company offers three core products: CANTAB® assessments, a flexible eCOA platform, and Quality Assurance Tools, which together enhance clinical trial outcomes, patient identification, and global efficiency in healthcare and pharmaceuticals.
YTD Price Performance: -39.79%
Average Trading Volume: 50,655
Technical Sentiment Consensus Rating: Buy
Current Market Cap: £12.98M
Learn more about COG stock on TipRanks’ Stock Analysis page.
